[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fx-WPAbzzna26-QkRxyGVcc21ZBT2vXe1sg8KaMvUyLI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":32,"phaseBuckets":48,"rows":55},"Corewell Health East",[4],130,false,13,5,93966,98,[13,16,19,21,23,25,27,29],{"name":14,"count":15},"Coronary Artery Disease",9,{"name":17,"count":18},"Interstitial Cystitis",6,{"name":20,"count":18},"Urinary Incontinence",{"name":22,"count":9},"Prostate Cancer",{"name":24,"count":9},"Overactive Bladder",{"name":26,"count":9},"Pelvic Pain",{"name":28,"count":9},"Chest Pain",{"name":30,"count":31},"COVID-19",4,[33,38,43],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT02870738","Bladder Directed vs. Pelvic Floor Therapy in IC\u002FBPS","2026-02-03","Bladder Instillations",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT06745388","Magnesium and Cramping","2026-09","Magnesium sulfate",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT05753046","Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain","2028-08","Early TAP Block",[49,50,51,52,53,54],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[56,108,131,149,167,191,219,237,267,285,303,321,352,370,388,406,430,457,475,504,530,548,573,602,627,645,670,699,717,742,766,791,816,851,886,913,938,964,982,1012,1030,1055,1079,1097,1122],{"intervention":57,"totalTrials":58,"cells":59},"Ketamine",3,{"EARLY_PHASE1":60,"PHASE1":63,"PHASE2":65,"PHASE3":81,"PHASE4":83,"NA":106},{"trials":61,"activeCount":62},[],0,{"trials":64,"activeCount":62},[],{"trials":66,"activeCount":62},[67],{"nctId":68,"briefTitle":69,"status":70,"phases":71,"primaryCompletion":72,"completion":72,"start":73,"enrollment":74,"conditions":75,"interventions":79},"NCT04365985","Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19","TERMINATED",[51],"2021-04-01","2020-04-29",70,[30,76,77,78],"Acute Respiratory Distress Syndrome","Severe Acute Respiratory Syndrome (SARS)","Coronavirus Infections",[80,57],"Naltrexone",{"trials":82,"activeCount":62},[],{"trials":84,"activeCount":105,"soonestReadout":41},[85,95],{"nctId":39,"briefTitle":40,"status":86,"phases":87,"primaryCompletion":41,"completion":41,"start":88,"enrollment":89,"conditions":90,"interventions":94},"RECRUITING",[53],"2025-07-29",150,[91,92,93],"Uterine Cramps","Postoperative Pain Management","Hysteroscopy",[42,57],{"nctId":96,"briefTitle":97,"status":70,"phases":98,"primaryCompletion":99,"completion":99,"start":100,"enrollment":9,"conditions":101,"interventions":103},"NCT03528512","IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair",[53],"2019-02-06","2018-09-04",[102],"Laceration of Skin",[57,104],"Midazolam and fentanyl",1,{"trials":107,"activeCount":62},[],{"intervention":47,"totalTrials":105,"cells":109},{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":118,"NA":129},{"trials":111,"activeCount":62},[],{"trials":113,"activeCount":62},[],{"trials":115,"activeCount":62},[],{"trials":117,"activeCount":62},[],{"trials":119,"activeCount":105,"soonestReadout":46},[120],{"nctId":44,"briefTitle":45,"status":121,"phases":122,"primaryCompletion":46,"completion":123,"start":124,"enrollment":125,"conditions":126,"interventions":127},"ENROLLING_BY_INVITATION",[53],"2029-08","2024-02-19",94,[22],[47,128],"Late TAP Block",{"trials":130,"activeCount":62},[],{"intervention":128,"totalTrials":105,"cells":132},{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":139,"PHASE4":141,"NA":147},{"trials":134,"activeCount":62},[],{"trials":136,"activeCount":62},[],{"trials":138,"activeCount":62},[],{"trials":140,"activeCount":62},[],{"trials":142,"activeCount":105,"soonestReadout":46},[143],{"nctId":44,"briefTitle":45,"status":121,"phases":144,"primaryCompletion":46,"completion":123,"start":124,"enrollment":125,"conditions":145,"interventions":146},[53],[22],[47,128],{"trials":148,"activeCount":62},[],{"intervention":42,"totalTrials":105,"cells":150},{"EARLY_PHASE1":151,"PHASE1":153,"PHASE2":155,"PHASE3":157,"PHASE4":159,"NA":165},{"trials":152,"activeCount":62},[],{"trials":154,"activeCount":62},[],{"trials":156,"activeCount":62},[],{"trials":158,"activeCount":62},[],{"trials":160,"activeCount":105,"soonestReadout":41},[161],{"nctId":39,"briefTitle":40,"status":86,"phases":162,"primaryCompletion":41,"completion":41,"start":88,"enrollment":89,"conditions":163,"interventions":164},[53],[91,92,93],[42,57],{"trials":166,"activeCount":62},[],{"intervention":37,"totalTrials":105,"cells":168},{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":185,"PHASE4":187,"NA":189},{"trials":170,"activeCount":62},[],{"trials":172,"activeCount":62},[],{"trials":174,"activeCount":105,"soonestReadout":36},[175],{"nctId":34,"briefTitle":35,"status":176,"phases":177,"primaryCompletion":36,"completion":178,"start":179,"enrollment":180,"conditions":181,"interventions":184},"ACTIVE_NOT_RECRUITING",[51],"2026-08","2017-04-21",128,[182,183],"Cystitis, Interstitial","Painful Bladder Syndrome",[37],{"trials":186,"activeCount":62},[],{"trials":188,"activeCount":62},[],{"trials":190,"activeCount":62},[],{"intervention":192,"totalTrials":105,"cells":193},"Proparacaine Hydrochloride ophthalmic solution, USP 0.5%",{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":202,"NA":217},{"trials":195,"activeCount":62},[],{"trials":197,"activeCount":62},[],{"trials":199,"activeCount":62},[],{"trials":201,"activeCount":62},[],{"trials":203,"activeCount":62},[204],{"nctId":205,"briefTitle":206,"status":70,"phases":207,"primaryCompletion":208,"completion":208,"start":209,"enrollment":210,"conditions":211,"interventions":215},"NCT04229771","Does Topical Ophthalmic Anesthetic Prior to Probing and Irrigation Decrease Pain?",[53],"2020-11-30","2020-06-30",2,[212,213,214],"Epiphora","Dacryostenosis","Dacryocystitis",[192,216],"Balanced salt solution",{"trials":218,"activeCount":62},[],{"intervention":216,"totalTrials":105,"cells":220},{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":227,"PHASE4":229,"NA":235},{"trials":222,"activeCount":62},[],{"trials":224,"activeCount":62},[],{"trials":226,"activeCount":62},[],{"trials":228,"activeCount":62},[],{"trials":230,"activeCount":62},[231],{"nctId":205,"briefTitle":206,"status":70,"phases":232,"primaryCompletion":208,"completion":208,"start":209,"enrollment":210,"conditions":233,"interventions":234},[53],[212,213,214],[192,216],{"trials":236,"activeCount":62},[],{"intervention":238,"totalTrials":105,"cells":239},"Acetaminophen 325 mg Oral",{"EARLY_PHASE1":240,"PHASE1":242,"PHASE2":244,"PHASE3":246,"PHASE4":248,"NA":265},{"trials":241,"activeCount":62},[],{"trials":243,"activeCount":62},[],{"trials":245,"activeCount":62},[],{"trials":247,"activeCount":62},[],{"trials":249,"activeCount":62},[250],{"nctId":251,"briefTitle":252,"status":253,"phases":254,"primaryCompletion":255,"completion":255,"start":256,"enrollment":257,"conditions":258,"interventions":261},"NCT04149964","Postoperative Pain Control in Septum and Sinus Surgery","COMPLETED",[53],"2022-09-21","2019-11-27",65,[259,260],"Post-operative Pain","Sinus Surgery",[238,262,263,264],"Acetaminophen 650 mg Oral","OxyCODONE 5 mg Oral","Acetaminophen\u002FHydrocodone 325 mg\u002F7.5 mg oral",{"trials":266,"activeCount":62},[],{"intervention":262,"totalTrials":105,"cells":268},{"EARLY_PHASE1":269,"PHASE1":271,"PHASE2":273,"PHASE3":275,"PHASE4":277,"NA":283},{"trials":270,"activeCount":62},[],{"trials":272,"activeCount":62},[],{"trials":274,"activeCount":62},[],{"trials":276,"activeCount":62},[],{"trials":278,"activeCount":62},[279],{"nctId":251,"briefTitle":252,"status":253,"phases":280,"primaryCompletion":255,"completion":255,"start":256,"enrollment":257,"conditions":281,"interventions":282},[53],[259,260],[238,262,263,264],{"trials":284,"activeCount":62},[],{"intervention":263,"totalTrials":105,"cells":286},{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":293,"PHASE4":295,"NA":301},{"trials":288,"activeCount":62},[],{"trials":290,"activeCount":62},[],{"trials":292,"activeCount":62},[],{"trials":294,"activeCount":62},[],{"trials":296,"activeCount":62},[297],{"nctId":251,"briefTitle":252,"status":253,"phases":298,"primaryCompletion":255,"completion":255,"start":256,"enrollment":257,"conditions":299,"interventions":300},[53],[259,260],[238,262,263,264],{"trials":302,"activeCount":62},[],{"intervention":264,"totalTrials":105,"cells":304},{"EARLY_PHASE1":305,"PHASE1":307,"PHASE2":309,"PHASE3":311,"PHASE4":313,"NA":319},{"trials":306,"activeCount":62},[],{"trials":308,"activeCount":62},[],{"trials":310,"activeCount":62},[],{"trials":312,"activeCount":62},[],{"trials":314,"activeCount":62},[315],{"nctId":251,"briefTitle":252,"status":253,"phases":316,"primaryCompletion":255,"completion":255,"start":256,"enrollment":257,"conditions":317,"interventions":318},[53],[259,260],[238,262,263,264],{"trials":320,"activeCount":62},[],{"intervention":322,"totalTrials":105,"cells":323},"Ropivacaine with NaCl",{"EARLY_PHASE1":324,"PHASE1":326,"PHASE2":328,"PHASE3":330,"PHASE4":332,"NA":350},{"trials":325,"activeCount":62},[],{"trials":327,"activeCount":62},[],{"trials":329,"activeCount":62},[],{"trials":331,"activeCount":62},[],{"trials":333,"activeCount":62},[334],{"nctId":335,"briefTitle":336,"status":253,"phases":337,"primaryCompletion":338,"completion":339,"start":340,"enrollment":341,"conditions":342,"interventions":345},"NCT02658149","Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty",[53],"2017-05-11","2017-06-02","2016-05",100,[343,344],"Osteoarthritis","Arthroplasty",[322,346,347,348,349],"Epinephrine","Morphine","Ketorolac Tromethamine","Ropivacaine",{"trials":351,"activeCount":62},[],{"intervention":346,"totalTrials":105,"cells":353},{"EARLY_PHASE1":354,"PHASE1":356,"PHASE2":358,"PHASE3":360,"PHASE4":362,"NA":368},{"trials":355,"activeCount":62},[],{"trials":357,"activeCount":62},[],{"trials":359,"activeCount":62},[],{"trials":361,"activeCount":62},[],{"trials":363,"activeCount":62},[364],{"nctId":335,"briefTitle":336,"status":253,"phases":365,"primaryCompletion":338,"completion":339,"start":340,"enrollment":341,"conditions":366,"interventions":367},[53],[343,344],[322,346,347,348,349],{"trials":369,"activeCount":62},[],{"intervention":347,"totalTrials":105,"cells":371},{"EARLY_PHASE1":372,"PHASE1":374,"PHASE2":376,"PHASE3":378,"PHASE4":380,"NA":386},{"trials":373,"activeCount":62},[],{"trials":375,"activeCount":62},[],{"trials":377,"activeCount":62},[],{"trials":379,"activeCount":62},[],{"trials":381,"activeCount":62},[382],{"nctId":335,"briefTitle":336,"status":253,"phases":383,"primaryCompletion":338,"completion":339,"start":340,"enrollment":341,"conditions":384,"interventions":385},[53],[343,344],[322,346,347,348,349],{"trials":387,"activeCount":62},[],{"intervention":348,"totalTrials":105,"cells":389},{"EARLY_PHASE1":390,"PHASE1":392,"PHASE2":394,"PHASE3":396,"PHASE4":398,"NA":404},{"trials":391,"activeCount":62},[],{"trials":393,"activeCount":62},[],{"trials":395,"activeCount":62},[],{"trials":397,"activeCount":62},[],{"trials":399,"activeCount":62},[400],{"nctId":335,"briefTitle":336,"status":253,"phases":401,"primaryCompletion":338,"completion":339,"start":340,"enrollment":341,"conditions":402,"interventions":403},[53],[343,344],[322,346,347,348,349],{"trials":405,"activeCount":62},[],{"intervention":407,"totalTrials":105,"cells":408},"Pylarify Piflufolastat Flourine-18",{"EARLY_PHASE1":409,"PHASE1":411,"PHASE2":413,"PHASE3":415,"PHASE4":417,"NA":428},{"trials":410,"activeCount":62},[],{"trials":412,"activeCount":62},[],{"trials":414,"activeCount":62},[],{"trials":416,"activeCount":62},[],{"trials":418,"activeCount":62},[419],{"nctId":420,"briefTitle":421,"status":422,"phases":423,"primaryCompletion":424,"completion":424,"start":425,"enrollment":62,"conditions":426,"interventions":427},"NCT05568537","Prostate MRI and Pylarify PSMA PET\u002FCT","WITHDRAWN",[53],"2026-10","2024-10",[22],[407],{"trials":429,"activeCount":62},[],{"intervention":431,"totalTrials":105,"cells":432},"OnabotulinumtoxinA 100Unit",{"EARLY_PHASE1":433,"PHASE1":435,"PHASE2":437,"PHASE3":439,"PHASE4":441,"NA":455},{"trials":434,"activeCount":62},[],{"trials":436,"activeCount":62},[],{"trials":438,"activeCount":62},[],{"trials":440,"activeCount":62},[],{"trials":442,"activeCount":62},[443],{"nctId":444,"briefTitle":445,"status":70,"phases":446,"primaryCompletion":447,"completion":447,"start":448,"enrollment":18,"conditions":449,"interventions":454},"NCT03523091","OnabotulinumtoxinA Bladder Injection Study",[53],"2020-09-01","2018-08-08",[24,450,451,20,452,453],"Overactive Bladder Syndrome","Urinary Urgency","Urinary Frequency\u002FUrgency","Urinary Bladder, Overactive",[431],{"trials":456,"activeCount":62},[],{"intervention":104,"totalTrials":105,"cells":458},{"EARLY_PHASE1":459,"PHASE1":461,"PHASE2":463,"PHASE3":465,"PHASE4":467,"NA":473},{"trials":460,"activeCount":62},[],{"trials":462,"activeCount":62},[],{"trials":464,"activeCount":62},[],{"trials":466,"activeCount":62},[],{"trials":468,"activeCount":62},[469],{"nctId":96,"briefTitle":97,"status":70,"phases":470,"primaryCompletion":99,"completion":99,"start":100,"enrollment":9,"conditions":471,"interventions":472},[53],[102],[57,104],{"trials":474,"activeCount":62},[],{"intervention":476,"totalTrials":105,"cells":477},"Povidone-iodine irrigation",{"EARLY_PHASE1":478,"PHASE1":480,"PHASE2":482,"PHASE3":484,"PHASE4":486,"NA":502},{"trials":479,"activeCount":62},[],{"trials":481,"activeCount":62},[],{"trials":483,"activeCount":62},[],{"trials":485,"activeCount":62},[],{"trials":487,"activeCount":62},[488],{"nctId":489,"briefTitle":490,"status":70,"phases":491,"primaryCompletion":492,"completion":493,"start":494,"enrollment":58,"conditions":495,"interventions":501},"NCT03447639","Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal",[53],"2018-10-18","2018-10-22","2018-03-29",[496,497,498,499,500],"Catheter; Infection (Indwelling Catheter)","Catheter Infection","Catheter-Related Infections","Catheter Bacteraemia","Urinary Tract Infections",[476],{"trials":503,"activeCount":62},[],{"intervention":505,"totalTrials":105,"cells":506},"Aliskiren",{"EARLY_PHASE1":507,"PHASE1":509,"PHASE2":511,"PHASE3":513,"PHASE4":515,"NA":528},{"trials":508,"activeCount":62},[],{"trials":510,"activeCount":62},[],{"trials":512,"activeCount":62},[],{"trials":514,"activeCount":62},[],{"trials":516,"activeCount":62},[517],{"nctId":518,"briefTitle":519,"status":422,"phases":520,"primaryCompletion":521,"completion":521,"start":522,"enrollment":62,"conditions":523,"interventions":526},"NCT00994253","Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics",[53],"2012-12","2009-08",[524,525],"Hypertension","Diabetes Type 2",[505,527],"Hydrochlorothiazide",{"trials":529,"activeCount":62},[],{"intervention":527,"totalTrials":105,"cells":531},{"EARLY_PHASE1":532,"PHASE1":534,"PHASE2":536,"PHASE3":538,"PHASE4":540,"NA":546},{"trials":533,"activeCount":62},[],{"trials":535,"activeCount":62},[],{"trials":537,"activeCount":62},[],{"trials":539,"activeCount":62},[],{"trials":541,"activeCount":62},[542],{"nctId":518,"briefTitle":519,"status":422,"phases":543,"primaryCompletion":521,"completion":521,"start":522,"enrollment":62,"conditions":544,"interventions":545},[53],[524,525],[505,527],{"trials":547,"activeCount":62},[],{"intervention":549,"totalTrials":105,"cells":550},"Vitamin D",{"EARLY_PHASE1":551,"PHASE1":553,"PHASE2":555,"PHASE3":557,"PHASE4":569,"NA":571},{"trials":552,"activeCount":62},[],{"trials":554,"activeCount":62},[],{"trials":556,"activeCount":62},[],{"trials":558,"activeCount":62},[559],{"nctId":560,"briefTitle":561,"status":253,"phases":562,"primaryCompletion":563,"completion":563,"start":564,"enrollment":565,"conditions":566,"interventions":568},"NCT01029392","Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements",[52],"2012-06","2009-11",75,[567],"Type 1 Diabetes Mellitus",[549],{"trials":570,"activeCount":62},[],{"trials":572,"activeCount":62},[],{"intervention":574,"totalTrials":105,"cells":575},"Tranexamic Acid",{"EARLY_PHASE1":576,"PHASE1":578,"PHASE2":580,"PHASE3":582,"PHASE4":598,"NA":600},{"trials":577,"activeCount":62},[],{"trials":579,"activeCount":62},[],{"trials":581,"activeCount":62},[],{"trials":583,"activeCount":62},[584],{"nctId":585,"briefTitle":586,"status":253,"phases":587,"primaryCompletion":588,"completion":589,"start":590,"enrollment":591,"conditions":592,"interventions":597},"NCT02043132","Tranexamic Acid in Reverse Total Shoulder Arthroplasty",[51,52],"2015-12","2016-02","2013-09",116,[593,594,595,596],"Shoulder Joint Disease","Complications; Arthroplasty","Intraoperative Complications","Blood Loss, Surgical",[574],{"trials":599,"activeCount":62},[],{"trials":601,"activeCount":62},[],{"intervention":603,"totalTrials":105,"cells":604},"COVID-19 convalescent plasma",{"EARLY_PHASE1":605,"PHASE1":607,"PHASE2":609,"PHASE3":621,"PHASE4":623,"NA":625},{"trials":606,"activeCount":62},[],{"trials":608,"activeCount":62},[],{"trials":610,"activeCount":62},[611],{"nctId":612,"briefTitle":613,"status":70,"phases":614,"primaryCompletion":615,"completion":616,"start":617,"enrollment":618,"conditions":619,"interventions":620},"NCT04432272","ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)",[51],"2020-11-13","2020-11-28","2020-07-16",71,[30,77,78],[603],{"trials":622,"activeCount":62},[],{"trials":624,"activeCount":62},[],{"trials":626,"activeCount":62},[],{"intervention":80,"totalTrials":105,"cells":628},{"EARLY_PHASE1":629,"PHASE1":631,"PHASE2":633,"PHASE3":639,"PHASE4":641,"NA":643},{"trials":630,"activeCount":62},[],{"trials":632,"activeCount":62},[],{"trials":634,"activeCount":62},[635],{"nctId":68,"briefTitle":69,"status":70,"phases":636,"primaryCompletion":72,"completion":72,"start":73,"enrollment":74,"conditions":637,"interventions":638},[51],[30,76,77,78],[80,57],{"trials":640,"activeCount":62},[],{"trials":642,"activeCount":62},[],{"trials":644,"activeCount":62},[],{"intervention":646,"totalTrials":105,"cells":647},"Ertapenem",{"EARLY_PHASE1":648,"PHASE1":650,"PHASE2":652,"PHASE3":664,"PHASE4":666,"NA":668},{"trials":649,"activeCount":62},[],{"trials":651,"activeCount":62},[],{"trials":653,"activeCount":62},[654],{"nctId":655,"briefTitle":656,"status":253,"phases":657,"primaryCompletion":658,"completion":658,"start":659,"enrollment":660,"conditions":661,"interventions":663},"NCT02159859","Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients",[51],"2016-04","2014-12",7,[662],"End Stage Renal Disease",[646],{"trials":665,"activeCount":62},[],{"trials":667,"activeCount":62},[],{"trials":669,"activeCount":62},[],{"intervention":671,"totalTrials":105,"cells":672},"Align Probiotic Supplement",{"EARLY_PHASE1":673,"PHASE1":675,"PHASE2":677,"PHASE3":693,"PHASE4":695,"NA":697},{"trials":674,"activeCount":62},[],{"trials":676,"activeCount":62},[],{"trials":678,"activeCount":62},[679],{"nctId":680,"briefTitle":681,"status":70,"phases":682,"primaryCompletion":683,"completion":683,"start":684,"enrollment":685,"conditions":686,"interventions":691},"NCT04175392","Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis",[50,51],"2022-03-01","2021-01-12",14,[687,688,689,690],"Fatty Liver Disease","Fibrosis, Liver","Cirrhosis, Liver","Steatohepatitis, Nonalcoholic",[671,692],"Placebos",{"trials":694,"activeCount":62},[],{"trials":696,"activeCount":62},[],{"trials":698,"activeCount":62},[],{"intervention":692,"totalTrials":105,"cells":700},{"EARLY_PHASE1":701,"PHASE1":703,"PHASE2":705,"PHASE3":711,"PHASE4":713,"NA":715},{"trials":702,"activeCount":62},[],{"trials":704,"activeCount":62},[],{"trials":706,"activeCount":62},[707],{"nctId":680,"briefTitle":681,"status":70,"phases":708,"primaryCompletion":683,"completion":683,"start":684,"enrollment":685,"conditions":709,"interventions":710},[50,51],[687,688,689,690],[671,692],{"trials":712,"activeCount":62},[],{"trials":714,"activeCount":62},[],{"trials":716,"activeCount":62},[],{"intervention":718,"totalTrials":105,"cells":719},"Heparin",{"EARLY_PHASE1":720,"PHASE1":722,"PHASE2":724,"PHASE3":736,"PHASE4":738,"NA":740},{"trials":721,"activeCount":62},[],{"trials":723,"activeCount":62},[],{"trials":725,"activeCount":62},[726],{"nctId":727,"briefTitle":728,"status":70,"phases":729,"primaryCompletion":730,"completion":730,"start":731,"enrollment":732,"conditions":733,"interventions":735},"NCT00445211","HEROIC (Heparin Requirement in Counterpulsation)",[51],"2008-03","2006-01",46,[734],"Cardiogenic Shock",[718],{"trials":737,"activeCount":62},[],{"trials":739,"activeCount":62},[],{"trials":741,"activeCount":62},[],{"intervention":743,"totalTrials":105,"cells":744},"Trimethoprim Sulfamethoxazole",{"EARLY_PHASE1":745,"PHASE1":747,"PHASE2":749,"PHASE3":760,"PHASE4":762,"NA":764},{"trials":746,"activeCount":62},[],{"trials":748,"activeCount":62},[],{"trials":750,"activeCount":62},[751],{"nctId":752,"briefTitle":753,"status":70,"phases":754,"primaryCompletion":755,"completion":755,"start":756,"enrollment":105,"conditions":757,"interventions":759},"NCT05418777","Treatment of Pneumocystis in COPD (the TOPIC Study)",[50,51],"2022-12-19","2022-09-28",[758],"COPD Exacerbation Acute",[743],{"trials":761,"activeCount":62},[],{"trials":763,"activeCount":62},[],{"trials":765,"activeCount":62},[],{"intervention":767,"totalTrials":105,"cells":768},"vitrectomy with subretinal lucentis",{"EARLY_PHASE1":769,"PHASE1":771,"PHASE2":783,"PHASE3":785,"PHASE4":787,"NA":789},{"trials":770,"activeCount":62},[],{"trials":772,"activeCount":62},[773],{"nctId":774,"briefTitle":775,"status":422,"phases":776,"primaryCompletion":777,"completion":777,"start":778,"enrollment":62,"conditions":779,"interventions":782},"NCT00538538","Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)",[50],"2008-10","2007-09",[780,781],"Retinal Hemorrhage","Macular Degeneration",[767,767],{"trials":784,"activeCount":62},[],{"trials":786,"activeCount":62},[],{"trials":788,"activeCount":62},[],{"trials":790,"activeCount":62},[],{"intervention":792,"totalTrials":105,"cells":793},"oral penicillin V",{"EARLY_PHASE1":794,"PHASE1":806,"PHASE2":808,"PHASE3":810,"PHASE4":812,"NA":814},{"trials":795,"activeCount":62},[796],{"nctId":797,"briefTitle":798,"status":70,"phases":799,"primaryCompletion":800,"completion":800,"start":801,"enrollment":802,"conditions":803,"interventions":805},"NCT00823433","Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood",[49],"2009-12","2009-01",25,[804],"Group B Streptococcus",[792],{"trials":807,"activeCount":62},[],{"trials":809,"activeCount":62},[],{"trials":811,"activeCount":62},[],{"trials":813,"activeCount":62},[],{"trials":815,"activeCount":62},[],{"intervention":817,"totalTrials":210,"cells":818},"Vancomycin",{"EARLY_PHASE1":819,"PHASE1":821,"PHASE2":823,"PHASE3":825,"PHASE4":827,"NA":839},{"trials":820,"activeCount":62},[],{"trials":822,"activeCount":62},[],{"trials":824,"activeCount":62},[],{"trials":826,"activeCount":62},[],{"trials":828,"activeCount":62},[829],{"nctId":830,"briefTitle":831,"status":253,"phases":832,"primaryCompletion":833,"completion":833,"start":834,"enrollment":835,"conditions":836,"interventions":838},"NCT02996487","Screening to Prophylax Against Clostridium Difficile Infection -",[53],"2023-06-28","2016-12-19",1294,[837],"Clostridium Difficile Infection",[817],{"trials":840,"activeCount":62},[841],{"nctId":842,"briefTitle":843,"status":70,"phases":844,"primaryCompletion":845,"completion":845,"start":846,"enrollment":210,"conditions":847,"interventions":849},"NCT01346059","Intracolonic Vancomycin Therapy in Severe C. Diff Colitis",[54],"2012-02","2011-04",[848],"Colitis",[817,850],"Saline",{"intervention":852,"totalTrials":210,"cells":853},"Ranolazine",{"EARLY_PHASE1":854,"PHASE1":856,"PHASE2":858,"PHASE3":860,"PHASE4":872,"NA":874},{"trials":855,"activeCount":62},[],{"trials":857,"activeCount":62},[],{"trials":859,"activeCount":62},[],{"trials":861,"activeCount":62},[862],{"nctId":863,"briefTitle":864,"status":70,"phases":865,"primaryCompletion":866,"completion":866,"start":867,"enrollment":868,"conditions":869,"interventions":871},"NCT01352416","Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery",[52],"2012-11","2010-09",15,[870],"Heart; Dysfunction Postoperative, Cardiac Surgery",[852],{"trials":873,"activeCount":62},[],{"trials":875,"activeCount":62},[876],{"nctId":877,"briefTitle":878,"status":70,"phases":879,"primaryCompletion":880,"completion":880,"start":881,"enrollment":882,"conditions":883,"interventions":885},"NCT00914316","Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities",[54],"2013-03","2009-05",29,[884],"Peripheral Arterial Disease",[852],{"intervention":349,"totalTrials":210,"cells":887},{"EARLY_PHASE1":888,"PHASE1":890,"PHASE2":892,"PHASE3":894,"PHASE4":896,"NA":902},{"trials":889,"activeCount":62},[],{"trials":891,"activeCount":62},[],{"trials":893,"activeCount":62},[],{"trials":895,"activeCount":62},[],{"trials":897,"activeCount":62},[898],{"nctId":335,"briefTitle":336,"status":253,"phases":899,"primaryCompletion":338,"completion":339,"start":340,"enrollment":341,"conditions":900,"interventions":901},[53],[343,344],[322,346,347,348,349],{"trials":903,"activeCount":62},[904],{"nctId":905,"briefTitle":906,"status":253,"phases":907,"primaryCompletion":908,"completion":909,"start":801,"enrollment":910,"conditions":911,"interventions":912},"NCT00672100","Initial Local Anesthetic Dose With Continuous Interscalene Analgesia",[54],"2010-02","2010-08",36,[259],[349,349,349],{"intervention":914,"totalTrials":105,"cells":915},"Enoxaparin",{"EARLY_PHASE1":916,"PHASE1":918,"PHASE2":920,"PHASE3":922,"PHASE4":924,"NA":926},{"trials":917,"activeCount":62},[],{"trials":919,"activeCount":62},[],{"trials":921,"activeCount":62},[],{"trials":923,"activeCount":62},[],{"trials":925,"activeCount":62},[],{"trials":927,"activeCount":62},[928],{"nctId":929,"briefTitle":930,"status":253,"phases":931,"completion":932,"start":933,"enrollment":934,"conditions":935,"interventions":937},"NCT00321009","LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin",[54],"2004-04","2000-03",60,[14,936],"Acute Myocardial Infarction",[914],{"intervention":939,"totalTrials":105,"cells":940},"ortho tricyclen",{"EARLY_PHASE1":941,"PHASE1":943,"PHASE2":945,"PHASE3":947,"PHASE4":949,"NA":951},{"trials":942,"activeCount":62},[],{"trials":944,"activeCount":62},[],{"trials":946,"activeCount":62},[],{"trials":948,"activeCount":62},[],{"trials":950,"activeCount":62},[],{"trials":952,"activeCount":62},[953],{"nctId":954,"briefTitle":955,"status":70,"phases":956,"primaryCompletion":957,"completion":958,"start":777,"enrollment":959,"conditions":960,"interventions":962},"NCT00775190","Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives",[54],"2013-10","2013-11",12,[961],"Contraception",[939,963],"Trinessa",{"intervention":963,"totalTrials":105,"cells":965},{"EARLY_PHASE1":966,"PHASE1":968,"PHASE2":970,"PHASE3":972,"PHASE4":974,"NA":976},{"trials":967,"activeCount":62},[],{"trials":969,"activeCount":62},[],{"trials":971,"activeCount":62},[],{"trials":973,"activeCount":62},[],{"trials":975,"activeCount":62},[],{"trials":977,"activeCount":62},[978],{"nctId":954,"briefTitle":955,"status":70,"phases":979,"primaryCompletion":957,"completion":958,"start":777,"enrollment":959,"conditions":980,"interventions":981},[54],[961],[939,963],{"intervention":983,"totalTrials":105,"cells":984},"ViviGen® Cellular Bone Matrix with DePuy Synthes Spinal Pedicle screw system",{"EARLY_PHASE1":985,"PHASE1":987,"PHASE2":989,"PHASE3":991,"PHASE4":993,"NA":995},{"trials":986,"activeCount":62},[],{"trials":988,"activeCount":62},[],{"trials":990,"activeCount":62},[],{"trials":992,"activeCount":62},[],{"trials":994,"activeCount":62},[],{"trials":996,"activeCount":62},[997],{"nctId":998,"briefTitle":999,"status":253,"phases":1000,"primaryCompletion":1001,"completion":1001,"start":1002,"enrollment":732,"conditions":1003,"interventions":1010},"NCT03733626","Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease",[54],"2024-06-25","2019-03-19",[1004,1005,1006,1007,1008,1009],"Lumbar Spondylolisthesis","Degenerative Disc Disease","Degenerative Spondylolisthesis","Lumbar Radiculopathy","Lumbar Spinal Stenosis","Lumbar Disc Disease",[983,1011],"Local Bone Autologous Bone Graft with DePuy Synthes Spinal pedicle screw system",{"intervention":1011,"totalTrials":105,"cells":1013},{"EARLY_PHASE1":1014,"PHASE1":1016,"PHASE2":1018,"PHASE3":1020,"PHASE4":1022,"NA":1024},{"trials":1015,"activeCount":62},[],{"trials":1017,"activeCount":62},[],{"trials":1019,"activeCount":62},[],{"trials":1021,"activeCount":62},[],{"trials":1023,"activeCount":62},[],{"trials":1025,"activeCount":62},[1026],{"nctId":998,"briefTitle":999,"status":253,"phases":1027,"primaryCompletion":1001,"completion":1001,"start":1002,"enrollment":732,"conditions":1028,"interventions":1029},[54],[1004,1005,1006,1007,1008,1009],[983,1011],{"intervention":1031,"totalTrials":105,"cells":1032},"COVID-19 vaccine",{"EARLY_PHASE1":1033,"PHASE1":1035,"PHASE2":1037,"PHASE3":1039,"PHASE4":1041,"NA":1043},{"trials":1034,"activeCount":62},[],{"trials":1036,"activeCount":62},[],{"trials":1038,"activeCount":62},[],{"trials":1040,"activeCount":62},[],{"trials":1042,"activeCount":62},[],{"trials":1044,"activeCount":62},[1045],{"nctId":1046,"briefTitle":1047,"status":253,"phases":1048,"primaryCompletion":1049,"completion":1049,"start":1050,"enrollment":1051,"conditions":1052,"interventions":1054},"NCT04912700","The Impact of Vaccination on Severity of Illness in COVID-19",[],"2021-06-07","2021-06-01",11834,[1053],"Covid19",[1031],{"intervention":1056,"totalTrials":105,"cells":1057},"Lidocaine",{"EARLY_PHASE1":1058,"PHASE1":1060,"PHASE2":1062,"PHASE3":1064,"PHASE4":1066,"NA":1068},{"trials":1059,"activeCount":62},[],{"trials":1061,"activeCount":62},[],{"trials":1063,"activeCount":62},[],{"trials":1065,"activeCount":62},[],{"trials":1067,"activeCount":62},[],{"trials":1069,"activeCount":62},[1070],{"nctId":1071,"briefTitle":1072,"status":253,"phases":1073,"primaryCompletion":1074,"completion":1074,"start":1075,"enrollment":1076,"conditions":1077,"interventions":1078},"NCT00441532","Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy",[54],"2006-08","2005-08",50,[22],[1056],{"intervention":850,"totalTrials":105,"cells":1080},{"EARLY_PHASE1":1081,"PHASE1":1083,"PHASE2":1085,"PHASE3":1087,"PHASE4":1089,"NA":1091},{"trials":1082,"activeCount":62},[],{"trials":1084,"activeCount":62},[],{"trials":1086,"activeCount":62},[],{"trials":1088,"activeCount":62},[],{"trials":1090,"activeCount":62},[],{"trials":1092,"activeCount":62},[1093],{"nctId":842,"briefTitle":843,"status":70,"phases":1094,"primaryCompletion":845,"completion":845,"start":846,"enrollment":210,"conditions":1095,"interventions":1096},[54],[848],[817,850],{"intervention":1098,"totalTrials":105,"cells":1099},"Standard Vancomycin",{"EARLY_PHASE1":1100,"PHASE1":1102,"PHASE2":1104,"PHASE3":1106,"PHASE4":1108,"NA":1110},{"trials":1101,"activeCount":62},[],{"trials":1103,"activeCount":62},[],{"trials":1105,"activeCount":62},[],{"trials":1107,"activeCount":62},[],{"trials":1109,"activeCount":62},[],{"trials":1111,"activeCount":62},[1112],{"nctId":1113,"briefTitle":1114,"status":422,"phases":1115,"primaryCompletion":564,"completion":1116,"start":1117,"enrollment":62,"conditions":1118,"interventions":1120},"NCT00861887","Extended Treatment With Vancomycin for Clostridium Difficile Colitis",[54],"2010-01","2009-02",[1119],"Clostridium Difficile Colitis",[1098,1121],"Extended Vancomycin",{"intervention":1121,"totalTrials":105,"cells":1123},{"EARLY_PHASE1":1124,"PHASE1":1126,"PHASE2":1128,"PHASE3":1130,"PHASE4":1132,"NA":1134},{"trials":1125,"activeCount":62},[],{"trials":1127,"activeCount":62},[],{"trials":1129,"activeCount":62},[],{"trials":1131,"activeCount":62},[],{"trials":1133,"activeCount":62},[],{"trials":1135,"activeCount":62},[1136],{"nctId":1113,"briefTitle":1114,"status":422,"phases":1137,"primaryCompletion":564,"completion":1116,"start":1117,"enrollment":62,"conditions":1138,"interventions":1139},[54],[1119],[1098,1121]]